Breast Cancer Survival Improves If Herceptin Is Used With Chemotherapy

Posted on December 14th, 2009 by Beth Backus

Science Daily
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.

Tags: Mayo Clinic Jacksonville

You must be logged-in to the site to post a comment.

Contact Us · Privacy Policy